Cardlytics Statistics
Share Statistics
Cardlytics has 52.5M
shares outstanding. The number of shares has increased by 6.77%
in one year.
| Shares Outstanding | 52.5M |
| Shares Change (YoY) | 6.77% |
| Shares Change (QoQ) | 2.48% |
| Owned by Institutions (%) | 60.62% |
| Shares Floating | n/a |
| Failed to Deliver (FTD) Shares | 38,710 |
| FTD / Avg. Volume | 3.58% |
Short Selling Information
The latest short interest is 8.33M, so 15.86% of the outstanding
shares have been sold short.
| Short Interest | 8.33M |
| Short % of Shares Out | 15.86% |
| Short % of Float | 18.53% |
| Short Ratio (days to cover) | 6.25 |
Valuation Ratios
The PE ratio is -0.95 and the forward
PE ratio is -1.43.
Cardlytics's PEG ratio is
-0.16.
| PE Ratio | -0.95 |
| Forward PE | -1.43 |
| PS Ratio | 0.64 |
| Forward PS | 0.3 |
| PB Ratio | 2.56 |
| P/FCF Ratio | -6.38 |
| PEG Ratio | -0.16 |
Financial Ratio HistoryEnterprise Valuation
Currently the Enterprise Value (EV) is not available for Cardlytics.
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 1.19,
with a Debt / Equity ratio of 3.17.
| Current Ratio | 1.19 |
| Quick Ratio | 1.19 |
| Debt / Equity | 3.17 |
| Debt / EBITDA | -1.45 |
| Debt / FCF | -7.88 |
| Interest Coverage | -21.96 |
Financial Efficiency
Return on Equity is n/a and Return on Invested Capital is n/a.
| Return on Equity | n/a |
| Return on Assets | n/a |
| Return on Invested Capital | n/a |
| Revenue Per Employee | $632,495.45 |
| Profits Per Employee | $-430,236.36 |
| Employee Count | 440 |
| Asset Turnover | 0.71 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | 0% |
Stock Price Statistics
The stock price has increased by -79.45% in the
last 52 weeks. The beta is 1.31, so Cardlytics's
price volatility has been higher than the market average.
| Beta | 1.31 |
| 52-Week Price Change | -79.45% |
| 50-Day Moving Average | 1.79 |
| 200-Day Moving Average | 3.06 |
| Relative Strength Index (RSI) | 46.56 |
| Average Volume (20 Days) | 1,081,493 |
Income Statement
In the last 12 months, Cardlytics had revenue of 278.3M
and earned -189.3M
in profits. Earnings per share was -3.91.
| Revenue | 278.3M |
| Gross Profit | 120.89M |
| Operating Income | -195.5M |
| Net Income | -189.3M |
| EBITDA | -152.53M |
| EBIT | -180.4M |
| Earnings Per Share (EPS) | -3.91 |
Full Income StatementBalance Sheet
The company has 65.59M in cash and 221.65M in
debt, giving a net cash position of -156.06M.
| Cash & Cash Equivalents | 65.59M |
| Total Debt | 221.65M |
| Net Cash | -156.06M |
| Retained Earnings | -1.3B |
| Total Assets | 369.07M |
| Working Capital | 24.98M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -8.82M
and capital expenditures -19.3M, giving a free cash flow of -28.12M.
| Operating Cash Flow | -8.82M |
| Capital Expenditures | -19.3M |
| Free Cash Flow | -28.12M |
| FCF Per Share | -0.58 |
Full Cash Flow StatementMargins
Gross margin is 43.44%, with operating and profit margins of -70.25% and -68.02%.
| Gross Margin | 43.44% |
| Operating Margin | -70.25% |
| Pretax Margin | -68.02% |
| Profit Margin | -68.02% |
| EBITDA Margin | -54.81% |
| EBIT Margin | -70.25% |
| FCF Margin | -10.1% |
